Get the app Watchlists Portfolios Alerts Sign in Get started

Menu

Jasper Therapeutics, Inc. JSPR

Full chart Compare

Set alert

0.49 USD -0.02 (-3.41%)

Nov 3, 2026, 3:43 PM EST

0.49 Day range 0.5299

0.315 52-week range 2.42

YTD: -73.19%
1 year: -76.63%

Funds holding JSPR, by value held
Fund	Value held	Weight in fund
VTI	$483.37K	0.00%
VXF	$180.98K	0.00%
IJE	$36.31K	0.00%
VBINX	$15.43K	0.00%

Held by insiders 4.98%

Held by institutions 100.34%

Float held by institutions 105.60%

Institutions 113

Top institutional holders
Holder	% held	Shares	Value	Reported
Velan Capital Investment Management LP	9.56%	1,433,828	31.72M	Sep 29, 2024
Soleus Capital Management, L.P.	8.96%	1,343,665	29.72M	Sep 29, 2024
Carlyle Group Inc.	7.11%	1,066,189	23.58M	Sep 29, 2024
Qiming U.s. Ventures Management, Llc	6.19%	928,964	20.55M	Sep 29, 2024
Blackrock Inc.	5.33%	800,028	17.70M	Sep 29, 2024
Vanguard Group Inc	4.63%	694,425	15.36M	Sep 29, 2024

Top mutual fund holders
Holder	% held	Shares	Value	Reported
Vanguard Total Stock Market Index Fund	2.67%	401,219	8.87M	Sep 29, 2024
iShares Russell 2000 ETF	1.98%	296,675	6.56M	Oct 30, 2024
Franklin Strategic Series-Franklin Biotechnology Discove	1.58%	236,841	5.24M	Jul 30, 2024
Vanguard Extended Market Index Fund	1.26%	188,656	4.17M	Sep 29, 2024
Fidelity Small Cap Index Fund	0.77%	115,362	2.55M	Aug 30, 2024
iShares Russell 2000 Growth ETF	0.67%	100,341	2.22M	Oct 30, 2024

JSPR insiders
Insider	Relation	Latest transaction	Date	Shares held
CARLYLE GROUP, INC.	Unknown	Purchase	Feb 7, 2024	0
EMSTER KURT VON	Director	Sale	Apr 12, 2023	21,175
FRENCH ANNA LOUISE	Director	Sale	Apr 13, 2023	23,750
LIS WILLIAM DAVID	Director	Sale	Oct 12, 2023	53,521
MAHAL JEETINDER SINGH	Chief Operating Officer	Conversion of Exercise of derivative security	Dec 11, 2024	25,009
QIMING U.S. HEALTHCARE FUND II, L.P.	Beneficial Owner of more than 10% of a Class of Security	Purchase	Jan 26, 2023	0